Penobscot Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358K Buy
3,461
+400
+13% +$35.7K 0.02% 259
2026
Q1
$220K Sell
3,061
-200
-6% -$15.4K 0.02% 300
2025
Q4
$259K Sell
3,261
-50
-2% -$3.94K 0.02% 282
2025
Q3
$250K Hold
3,311
0.02% 287
2025
Q2
$228K Buy
3,311
+150
+5% +$9.84K 0.02% 289
2025
Q1
$214K Buy
+3,161
New +$189K 0.02% 289
2024
Q4
Sell
-5,021
Closed -$316K 304
2024
Q3
$316K Sell
5,021
-3,255
-39% -$190K 0.03% 256
2024
Q2
$489K Sell
8,276
-4,856
-37% -$304K 0.05% 204
2024
Q1
$1.05M Sell
13,132
-2,900
-18% -$222K 0.11% 147
2023
Q4
$1.27M Sell
16,032
-1,972
-11% -$140K 0.15% 127
2023
Q3
$1.26M Sell
18,004
-45
-0.2% -$3.19K 0.17% 116
2023
Q2
$1.25M Sell
18,049
-60
-0.3% -$4.27K 0.21% 104
2023
Q1
$1.35M Sell
18,109
-80
-0.4% -$6.71K 0.23% 98
2022
Q4
$1.7M Sell
18,189
-36
-0.2% -$3.47K 0.3% 82
2022
Q3
$1.74M Hold
18,225
0.32% 79
2022
Q2
$1.69M Sell
18,225
-235
-1% -$22.9K 0.29% 84
2022
Q1
$1.87M Sell
18,460
-64
-0.3% -$6.72K 0.27% 91
2021
Q4
$1.91M Sell
18,524
-1,490
-7% -$138K 0.26% 88
2021
Q3
$1.7M Sell
20,014
-710
-3% -$59.5K 0.25% 96
2021
Q2
$1.73M Sell
20,724
-1,148
-5% -$94K 0.26% 95
2021
Q1
$1.65M Sell
21,872
-4,595
-17% -$335K 0.26% 97
2020
Q4
$1.81M Buy
26,467
+225
+0.9% +$14.6K 0.3% 78
2020
Q3
$1.53M Sell
26,242
-2,252
-8% -$140K 0.29% 81
2020
Q2
$1.85M Sell
28,494
-2,250
-7% -$142K 0.38% 69
2020
Q1
$1.82M Sell
30,744
-4,396
-13% -$293K 0.43% 63
2019
Q4
$2.61M Sell
35,140
-3,929
-10% -$276K 0.49% 62
2019
Q3
$2.46M Sell
39,069
-3,946
-9% -$234K 0.49% 63
2019
Q2
$2.34M Sell
43,015
-7,200
-14% -$388K 0.48% 65
2019
Q1
$2.71M Sell
50,215
-14,580
-23% -$900K 0.57% 56
2018
Q4
$4.25M Buy
64,795
+6,190
+11% +$462K 1.02% 35
2018
Q3
$4.61M Sell
58,605
-5,250
-8% -$375K 1% 30
2018
Q2
$4.11M Sell
63,855
-4,515
-7% -$298K 0.96% 30
2018
Q1
$4.25M Buy
68,370
+12,960
+23% +$930K 1.02% 31
2017
Q4
$4.02M Sell
55,410
-10,410
-16% -$757K 1.11% 30
2017
Q3
$5.35M Buy
65,820
+170
+0.3% +$13.4K 1.6% 14
2017
Q2
$5.28M Buy
65,650
+886
+1% +$70K 1.7% 11
2017
Q1
$5.08M Buy
64,764
+2,250
+4% +$180K 1.7% 12
2016
Q4
$4.93M Sell
62,514
-1,515
-2% -$123K 1.71% 13
2016
Q3
$5.7M Buy
64,029
+1,205
+2% +$114K 2% 6
2016
Q2
$6.01M Buy
62,824
+2,515
+4% +$251K 2.15% 5
2016
Q1
$6.26M Sell
60,309
-17,610
-23% -$1.71M 2.34% 4
2015
Q4
$7.62M Buy
77,919
+725
+0.9% +$71K 2.39% 4
2015
Q3
$7.45M Sell
77,194
-755
-1% -$79.4K 2.49% 4
2015
Q2
$8.18M Buy
77,949
+1,830
+2% +$187K 2.54% 4
2015
Q1
$7.86M Buy
76,119
+1,470
+2% +$149K 2.49% 4
2014
Q4
$7.19M Buy
74,649
+1,640
+2% +$145K 2.26% 7
2014
Q3
$5.81M Buy
73,009
+590
+0.8% +$46.5K 1.93% 9
2014
Q2
$5.46M Buy
72,419
+752
+1% +$56.8K 1.83% 10
2014
Q1
$5.37M Buy
71,667
+990
+1% +$69.9K 1.9% 9
2013
Q4
$5.06M Buy
70,677
+1,640
+2% +$105K 1.79% 11
2013
Q3
$3.92M Buy
69,037
+4,290
+7% +$256K 1.54% 14
2013
Q2
$3.7M Buy
+64,747
New +$3.75M 1.54% 14

Other funds holding CVS

Penobscot Investment Management's CVS Position: Q2 2026 in Review

Penobscot Investment Management increased its CVS Health (CVS) stake by 13% in Q2 2026, buying an estimated $35.7K and bringing the position to 3,461 shares worth $358K. The position accounts for 0.02% of the portfolio, ranked #259.

Penobscot Investment Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.18M in Q2 2015. 653 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Penobscot Investment Management held 3,461 shares of CVS Health worth $358K as of Q2 2026.
  • Penobscot Investment Management bought 400 CVS Health shares in Q2 2026, an estimated $35.7K.
  • CVS Health made up 0.02% of Penobscot Investment Management's portfolio in Q2 2026, its #259 holding.
  • Penobscot Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Penobscot Investment Management's CVS Health position peaked at $8.18M in Q2 2015.
  • 653 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.